Is Genmab A/S (GMAB) a Buy, Sell, or Hold?
NASDAQ : GMAB
Genmab A/S — Analyst Ratings
$28.52 USD
-$0.48 (-1.66%)
- Volume
- 0
- Average Volume
- 1.94M
- Market Capitalization
- $17.51B
- P/E Ratio
- 21.55
- Dividend Yield
- 0.00%
- Price Target
- $40.00
- Year High
- $35.43
- Year Low
- $21.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.18
Analyst Consensus Summary
Consensus Rating
Neutral
18 Analysts
Rating Score
3/5
Recommendation Strength
Upside/Downside
-28.7%
vs Current Price
Price Target
$40.00
Average TargetPrice Target Range
Lowest Target
$32.00
-10.9% DOWNSIDE
Average Target
$40.00
Median Estimate
Highest Target
$43.00
-33.7% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 18
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 13 | 4 | 1 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Truist Financial | Gregory Renza | $40 | $26.89 | 2026-05-27 06:09 AM | 48.8% |
| Guggenheim | Michael Schmidt | $40 | $29.29 | 2026-02-23 06:31 AM | 36.6% |
| Jefferies | Benjamin Jackson | $41.5 | $30.03 | 2026-02-17 04:26 AM | 38.2% |
| Truist Financial | Asthika Goonewardene | $48 | $28.84 | 2025-11-06 03:03 PM | 66.4% |
| Truist Financial | Asthika Goonewardene | $49 | $33.56 | 2025-10-06 07:12 AM | 46.0% |